Corneal Cross Linking Treatment for Keratoconus now in India

The method works by increasing collagen cross linking, which are the natural anchors within the cornea

Corneal Collagen Cross linking with Riboflavin (C3-R), a treatment for keratoconus, a disease of the cornea, recently was pioneered in India by Mumbai’s Dr Vinay Agarwal of Clear Vision Eye centre, a corneal surgeon specialising in keratoconus management.

Keratoconus makes the cornea become weak and it may gradually bulge outward. Most often, this bulging is in the lower half of the cornea and first presents as astigmatism. “However, not all astigmatism is due to keratoconus. In mild or early stages of Keratoconus (forme fruste keratoconus), eyeglasses may correct the astigmatic vision,” informs Dr Agarwal. Continue reading

Clinical Management of Keratoconus

Corneal Collagen Cross-linking Treatment

Corneal collagen cross-linking induced by treatment of impregnating Riboflavin (B2) in to the cornea and exposure to ultraviolet-A light is a safe and effective, minimally invasive procedure both to reduce disease progression, increase the strength of the cornea and to improve upon the cornea’s optical properties in eyes with early keratoconus.

As long as keratoconus is diagnosed early enough – a stabilization of clinical findings and visual acuity can be achieved without a need for a corneal transplant or further progression. Continue reading